By Devika Patel
Knoxville, Tenn., Dec. 17 - Helix BioPharma Corp. announced it plans a C$16.87 million private placement of stock.
The company will sell 10.04 million shares at C$1.68 per share.
Proceeds will be used for working capital.
The company expects to close the private placement within the next 10 days.
Aurora, Ont.-based Helix BioPharma is a biopharmaceutical company developing products for the treatment of cancer and pre-cancerous conditions.
| Issuer: | Helix BioPharma Corp.
|
| Issue: | Common shares
|
| Amount: | C$16,867,200
|
| Shares: | 10.04 million
|
| Price: | C$1.68
|
| Warrants: | No
|
| Pricing date: | Dec. 17
|
| Stock symbol: | Toronto: HBP
|
| Stock price: | C$2.15 at close Dec. 14
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
